AU7824391A - Recombinant dna and process for the production of chimeric antibodies - Google Patents

Recombinant dna and process for the production of chimeric antibodies

Info

Publication number
AU7824391A
AU7824391A AU78243/91A AU7824391A AU7824391A AU 7824391 A AU7824391 A AU 7824391A AU 78243/91 A AU78243/91 A AU 78243/91A AU 7824391 A AU7824391 A AU 7824391A AU 7824391 A AU7824391 A AU 7824391A
Authority
AU
Australia
Prior art keywords
production
recombinant dna
chimeric antibodies
chimeric
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU78243/91A
Other versions
AU629752B2 (en
Inventor
Brigitte Kaluza
Walter Knapp
Ulrich H. Weidle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU7824391A publication Critical patent/AU7824391A/en
Application granted granted Critical
Publication of AU629752B2 publication Critical patent/AU629752B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU78243/91A 1990-06-08 1991-06-07 Recombinant dna and process for the production of chimeric antibodies Ceased AU629752B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4018442 1990-06-08
DE4018442A DE4018442A1 (en) 1990-06-08 1990-06-08 RECOMBINANT DNA AND METHOD FOR PRODUCING CHIMERIC ANTIBODIES

Publications (2)

Publication Number Publication Date
AU7824391A true AU7824391A (en) 1991-12-12
AU629752B2 AU629752B2 (en) 1992-10-08

Family

ID=6408075

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78243/91A Ceased AU629752B2 (en) 1990-06-08 1991-06-07 Recombinant dna and process for the production of chimeric antibodies

Country Status (15)

Country Link
EP (1) EP0460674A3 (en)
JP (1) JPH04330286A (en)
KR (1) KR920000922A (en)
AU (1) AU629752B2 (en)
CA (1) CA2043516A1 (en)
CS (1) CS175691A3 (en)
DE (1) DE4018442A1 (en)
FI (1) FI912763A (en)
HU (1) HUT58795A (en)
IE (1) IE911808A1 (en)
IL (1) IL98403A0 (en)
NO (1) NO912192L (en)
NZ (1) NZ238383A (en)
PT (1) PT97916A (en)
ZA (1) ZA914363B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173494A3 (en) * 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
KR900700134A (en) * 1988-04-15 1990-08-11 원본미기재 IL-2 Receptor-Specific Chimeric Antibodies

Also Published As

Publication number Publication date
IE911808A1 (en) 1991-12-18
EP0460674A2 (en) 1991-12-11
CS175691A3 (en) 1992-01-15
HUT58795A (en) 1992-03-30
NZ238383A (en) 1993-10-26
HU911919D0 (en) 1991-12-30
EP0460674A3 (en) 1992-08-19
AU629752B2 (en) 1992-10-08
ZA914363B (en) 1992-03-25
FI912763A (en) 1991-12-09
IL98403A0 (en) 1992-07-15
DE4018442A1 (en) 1991-12-12
JPH04330286A (en) 1992-11-18
KR920000922A (en) 1992-01-29
NO912192L (en) 1991-12-09
NO912192D0 (en) 1991-06-07
CA2043516A1 (en) 1991-12-09
PT97916A (en) 1992-03-31
FI912763A0 (en) 1991-06-07

Similar Documents

Publication Publication Date Title
GB2193499B (en) Process for the genetic modification of yeast
AU625613B2 (en) Novel chimeric antibodies
EP0509841A3 (en) Co-expression system of protein disulfide isomerase gene and useful polypeptide gene and process for producing the polypeptide using its system
AU7762691A (en) Process for producing protein
AU2999389A (en) Process for the production of nitriles and oxides
AU1322692A (en) Method for the in vitro production of protein from a dna sequence without cloning
AU2889489A (en) Process for the production of nitriles and oxides
HU9200293D0 (en) Process for the production of monoclonal antibodies and their fragments
EP0327000A3 (en) Gene fragments coding for the variable region of an anti-hiv antibody, chimeric anti-hiv antibodies expressed using the same, and process for their preparation
AU1446988A (en) Genetic engineering process for the preparation of polypeptides
AU7291891A (en) Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
AU7548291A (en) Process for purifying polypeptide
EP0181121A3 (en) Novel polypeptide and process for producing the same
AU2753595A (en) Novel protein and process for producing the same
AU5207193A (en) Process for the production of polypeptides
GB9022152D0 (en) Improved methods for the production of proteins
AU7824391A (en) Recombinant dna and process for the production of chimeric antibodies
GB8830171D0 (en) Gene capable of enhancing s-adenosyl-1-methionine accumulation and process for producing s-adenosyl-1-methionine using the same
AU3271089A (en) Process for the preparation of alkanediols
AU2299588A (en) Process for the production of polyethylene
GB2248839B (en) Process for the separation of proteins or polypeptides
AU610736B2 (en) Process for the production of proteins
EP0858438A4 (en) Process for the production of ceramic materials
AU3136589A (en) Process for the preparation of alkanediols
AU9054882A (en) Process for the genetic modification of cerials with transformation vectors